中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

经颈静脉肝内门体分流术的并发症及其防治

薛挥 李培杰 李伟之 苏静文 黄金

薛挥, 李培杰, 李伟之, 苏静文, 黄金. 经颈静脉肝内门体分流术的并发症及其防治[J]. 临床肝胆病杂志, 2016, 32(2): 238-241. DOI: 10.3969/j.issn.1001-5256.2016.02.007
引用本文: 薛挥, 李培杰, 李伟之, 苏静文, 黄金. 经颈静脉肝内门体分流术的并发症及其防治[J]. 临床肝胆病杂志, 2016, 32(2): 238-241. DOI: 10.3969/j.issn.1001-5256.2016.02.007
Xue Hui, Li PeiJie, Li WeiZhi, Su JingWen, Huang Jin. Prevention and treatment of complications after transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol, 2016, 32(2): 238-241. DOI: 10.3969/j.issn.1001-5256.2016.02.007
Citation: Xue Hui, Li PeiJie, Li WeiZhi, Su JingWen, Huang Jin. Prevention and treatment of complications after transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol, 2016, 32(2): 238-241. DOI: 10.3969/j.issn.1001-5256.2016.02.007

经颈静脉肝内门体分流术的并发症及其防治

DOI: 10.3969/j.issn.1001-5256.2016.02.007
详细信息
  • 中图分类号: R575.2

Prevention and treatment of complications after transjugular intrahepatic portosystemic shunt

  • 摘要: 经颈静脉肝内门体分流术(TIPS)在治疗肝硬化门静脉高压的应用已得到国内外同行的广泛认可。就TIPS出现的腹腔内出血、急性肺栓塞等致死性并发症和分流道失效、反复出现的分流性肝性脑病,进行了重点描述,并就其形成的原因及如何防范作了详尽的阐述。旨在提高TIPS术中穿刺的精准性和安全性,减少TIPS术后分流道失效、肝性脑病等常见并发症的发生,提高TIPS在治疗肝硬化门静脉高压症应用中的临床疗效。

     

  • [1]SAAD WE,SAAD NE,DAVIES MG,et al.Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates:preliminary results[J].J Vasc Interv Radiol,2006,17(6):995-1002.
    [2]FUNAKI B.Transjugular intrahepatic portosystemic shunt[J].Semin Intervent Radiol,2008,25(2):168-174.
    [3]BOYER TD,HASKAL ZJ.American Association for the Study of Liver Diseases.The Role of transjugular intrahepatic portosystemic shunt(TIPS)in the management of portal hypertension:update2009[J].Hepatology,2010,51(1):306.
    [4]FIDELMAN N,KWAN SW,LABERGE JM,et al.The transjugular intrahepatic portosystemic shunt:an update[J].AJR Am J Roentgenol,2012,199(4):746-755.
    [5]XUE H,CHANG XM,HAO ZM,et al.Complicative results and hepatic hemodynamic changes in transjugular intrahepatic portosystemic shunt[J].J Xi'an Med Univ,1998,19(3):449-451.(in Chinses)薛挥,苌新明,郝志明,等.TIPS对肝血流动力学影响及并发症的观察[J].西安医科大学学报,1998,19(3):449-451.
    [6]CHU JG,PIAO LS,CHEN ZY,et al.Portosystemie shunt via the left braneh of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt[J].Chin J Hepatol,2002,10(6):437-440.(in Chinses)诸建国,朴龙松,陈肇一,等.门静脉左支分流降低术后肝性脑病的临床研究[J].中华肝脏病杂志,2002,10(6):437-440.
    [7]XUE H,LYU LS,HAO ZM,et al.Review of the transjugular inirahepatic portosystemic stent shunt(Tipss)in treatment of portal hypertension in the past 12 years(analysis of 215 cases)[J].China J Modern Med,2007,17(15):1863-1866.(in Chinses)薛挥,吕良山,郝志明,等.经颈静脉肝内门腔静脉内支架分流术(TIPSS)治疗门脉高压症(附215例分析)[J].中国现代医学杂志,2007,17(15):1863-1866.
    [8]CHEN S,LI X,WEI B,et al.Recurrent variceal bleeding and shunt patency:prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization[J].Radiology,2013,268(3):900-906.
    [9]TENG GJ,LU Q.Bile Leakage during Transjugular intrahepatic portosystemic shunt creation:in vitro effect of bile on growth and function of human umbilical vein endothelium1[J].Radiology,2005,235(3):867-871.
    [10]ROSSI P,SALVATORI FM,FANELLI F,et al.Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation:3-year experience[J].Radiology,2004,231(3):820-830.
    [11]BUREAU C,GARCIA-PAGAN JC,LAYRARGUES GP,et al.Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts:longterm results of a randomized multicentre study[J].Liver Int,2007,27(6):742-747.
    [12]SAAD WE,DARWISH WM,DAVIES MG,et al.Stent-grafts for transjugular intrahepatic portosystemic shunt creation:specialized TIPS stent-graft versus generic stent-graft/bare stent combination[J].J Vasc Interv Radiol,2010,21(10):1512-1520.
    [13]JUNG HS,KALVA SP,GREENFIELD AJ,et al.TIPS:comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts[J].J Vasc Interv Radiol,2009,20(2):180-185.
    [14]WU XJ,CAO JM,HAN JM,et al.The retrospective study of transjugular intrahepatic portosystemic shunt with covered or uncovered stents in patients with portal hypertension[J].Chin J Surg,2010,8(2):83-87.(in Chinese)吴性江,曹建民,韩建明,等.覆膜支架和裸支架行TIPS治疗门静脉高压症的对比研究[J].中华外科杂志,2010,8(2):83-87.
    [15]TRIPATHI D,REDHEAD D.Transjugular intrahepatic portosystemic stent-shunt:technical factors and new developments[J].Eur J Gastroenterol Hepatol,2006,18(11):1127-1133.
    [16]WANG CM,LI X,FU J,et al.Technological modification of transjugular intrahepatic portosystemic shunt:the precise covering of parenchymal shunt with stent-graft[J].J Peking Univ:Health Sci,2014,46(1):165-168.(in Chinses)王昌明,李选,傅军,等.肝实质段覆膜支架精确覆盖技术在经颈静脉肝内门体分流术中的应用[J].北京大学学报:医学版,2014,46(1):165-168.
    [17]LI WZ,WEI W,SHEN C,et al.Recanalization for shunt failure after TIPS with ultrasound-guided percutaneous transhepatic retrograde stent:a report of two cases[J].Shaanxi Med J,2015,44(10):1440-1441.(in Chinses)李伟之,魏炜,沈灿,等.超声引导下经皮经肝穿刺支架逆行TIPS术后分流道失效再通术2例[J].陕西医学杂志,2015,44(10):1440-1441.
    [18]Group of Gastrointestinal Intervention,Chinese Society of Gastroenterology,Chinese Medical Association.Consensus on transjugular intrahepatic portosystemic shunt for treatment of cirrhotic portal hypertension[J].J Clin Hepatol,2014,30(3):210-213.(in Chinses)中华医学会消化病学分会消化介入学组.经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压共识意见[J].临床肝胆病杂志,2014,30(3):210-213.
    [19]XUE H,JIAO JY,LYU LS,et al.Clinical efficacy and the changes of blood NO,IL-6 and MDA in TIPS[J].J Xi'an Jiaotong Univ:Med Sci,2008,29(1):62-65.(in Chinses)薛挥,焦婕英,吕良山,等.经颈静脉肝内门体分流术治疗肝硬化门脉高压症对机体液递物质的影响及疗效[J].西安交通大学学报:医学版,2008,29(1):62-65.
    [20]XUE H,YUAN J,LI YC,et al.Follow-up study of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension[J].Dig Dis Sci,2011,56(11):3350-3356.
    [21]XUE H,LIU YE.Clinical significance of changes in portal vein hemodynamics[J].Shaanxi Med J,2000,29(5):288-290.(in Chinses)薛挥,刘彦娥.门静脉血液动力学改变的临床意义[J].陕西医学杂志,2000,29(5):288-290.
    [22]HAUSEGGER KA,KARNEL F,GEORGIEVA B,et al.Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft[J].J Vasc Interv Radiol,2004,15(3):239-248.
    [23]SAUERBRUCH T,MENGEL M,DOLLINGER M,et al.Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents vs hemodynamically controlled medical therapy[J].Gastroenterology,2015,149(3):660-668.
    [24]NITIN KA,WINSTON AA,STEPHER HC.Direct acting inhibitors of ammoniagenesis:a role in post-TIPS encephalopathy?[J].Ann Hepatol,2014,13(2):179-186.
    [25]XUE H.Postoperative complications of transjugular intrahepatic portosystemic stent-shunt:a report of two cases[J].Shaanxi Med J,1996,25(6):375-376.(in Chinses)薛挥.经颈静脉肝内门体静脉内支架分流术后并发症2例[J].陕西医学杂志,1996,25(6):375-376.
  • 加载中
计量
  • 文章访问数:  2335
  • HTML全文浏览量:  12
  • PDF下载量:  485
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-12-09
  • 出版日期:  2016-02-20
  • 刊出日期:  2016-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回